Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Assenat · SciRah

Researcher profile · Semantic Scholar

E. Assenat

Share profile

E. Assenat — researcher profile on SciRah

h-index: 51
Works: 259
Citations: 22K

Most-cited papers

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
T. Yau, Joong-Won Park, R. Finn, A. Cheng +23 more
2021The Lancet Oncology930 citations
Semantic Scholar
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
E. Garin, L. Tselikas, B. Guiu, J. Chalaye +23 more
2020The Lancet Gastroenterology and Hepatology502 citations Open access
Semantic Scholar
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.
J. Edeline, M. Benabdelghani, A. Bertaut, J. Watelet +20 more
2019Journal of Clinical Oncology464 citations
Semantic Scholar
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
T. Conroy, F. Castan, A. Lopez, A. Turpin +14 more
2022JAMA Oncology316 citations Open access
Semantic Scholar
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
R. Kelley, E. Gane, E. Assenat, J. Siebler +10 more
2019Clinical and Translational Gastroenterology213 citations Open access
Semantic Scholar
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
Shu-Kui Qin, M. Kudo, T. Meyer, Yuxian Bai +12 more
2023JAMA Oncology210 citations Open access
Semantic Scholar
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
L. Hountondji, Christophe Ferreira De Matos, F. Lebossé, X. Quantin +16 more
2023JHEP Reports84 citations Open access
Semantic Scholar
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
S. Chan, M. Schuler, Yoon-Koo Kang, C. Yen +32 more
2022Journal of experimental & clinical cancer research : CR75 citations Open access
Semantic Scholar
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial
Zheng-Gang Ren, M. Ducreux, G. Abou-Alfa, P. Merle +26 more
2022Liver Cancer67 citations Open access
Semantic Scholar
LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
S. Qin, M. Kudo, T. Meyer, R. Finn +16 more
2022Annals of Oncology63 citations Open access
Semantic Scholar
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
A. Zhu, R. Finn, Yoon-Koo Kang, C. Yen +18 more
2021British Journal of Cancer58 citations Open access
Semantic Scholar
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
T. Walter, A. Lièvre, R. Coriat, D. Malka +17 more
2023The Lancet Oncology41 citations Open access
Semantic Scholar
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
M. Kudo, P. Galle, G. Brandi, Yoon-Koo Kang +17 more
2020JHEP Reports41 citations Open access
Semantic Scholar
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
L. Cayrefourcq, F. Thomas, T. Mazard, E. Assenat +2 more
2021Molecular Cancer38 citations Open access
Semantic Scholar
Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients
M. Hermida, C. Cassinotto, L. Piron, S. Aho-Glele +7 more
2020Cancers35 citations Open access
Semantic Scholar
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study
M. Michalet, K. Bordeau, M. Cantaloube, S. Valdenaire +15 more
2022Frontiers in Oncology34 citations Open access
Semantic Scholar
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series
Cyrille Coustal, J. Vanoverschelde, X. Quantin, C. Lesage +21 more
2023Journal for ImmunoTherapy of Cancer33 citations Open access
Semantic Scholar
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial
M. Ychou, M. Rivoire, S. Thézénas, R. Guimbaud +18 more
2022British Journal of Cancer33 citations Open access
Semantic Scholar
O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma
M. Ducreux, G. Abou-Alfa, Zheng-Gang Ren, J. Edeline +16 more
2021Annals of Oncology31 citations Open access
Semantic Scholar
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study
K. Bordeau, M. Michalet, A. Keskes, S. Valdenaire +17 more
2022Cancers30 citations Open access
Semantic Scholar
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2
M. Kudo, P. Galle, J. Llovet, R. Finn +18 more
2020Liver international (Print)30 citations Open access
Semantic Scholar
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression
T. Decaens, C. Barone, E. Assenat, M. Wermke +13 more
2021British Journal of Cancer29 citations Open access
Semantic Scholar
Machine Learning‐Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening
R. Tanos, G. Tosato, A. Otandault, Z. Al Amir Dache +19 more
2020Advancement of science29 citations Open access
Semantic Scholar
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first‐line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1)
E. Assenat, L. Mineur, C. Mollevi, E. Lopez-Crapez +10 more
2021International Journal of Cancer27 citations Open access
Semantic Scholar
Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01).
E. Garin, Lambros Tzelikas, B. Guiu, J. Chalaye +11 more
202027 citations
Semantic Scholar
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial.
P. Merle, J. Blanc, J. Edeline, K. Le Malicot +14 more
2023Digestive and Liver Disease25 citations Open access
Semantic Scholar
Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer
A. Thierry, B. Pastor, E. Pisareva, F. Ghiringhelli +24 more
2021JAMA Network Open24 citations Open access
Semantic Scholar
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82)
A. Vienot, M. Jacquin, M. Rebucci-Peixoto, Dimitri Pureur +20 more
2023BMC Cancer22 citations Open access
Semantic Scholar
Life expectancy of patients with hepatocellular carcinoma according to the upfront treatment: A nationwide analysis.
C. Cassinotto, E. Nogué, Quentin Durand, F. Panaro +5 more
2023Diagnostic and Interventional Imaging21 citations Open access
Semantic Scholar
Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
M. Expósito, M. Akce, J. Alvarez, E. Assenat +11 more
2019Journal of Vascular and Interventional Radiology21 citations Open access
Semantic Scholar
714P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
S. Chan, M. Kudo, B. Sangro, R. K. Kelley +16 more
2022Annals of Oncology20 citations Open access
Semantic Scholar
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
E. Deshayes, E. Assenat, Laetitia Meignant, M. Bardiès +2 more
2022BMC Cancer20 citations Open access
Semantic Scholar
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
K. Bordeau, M. Michalet, A. Keskes, S. Valdenaire +18 more
2023Journal of Clinical Medicine19 citations Open access
Semantic Scholar
Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery
Mohamad Azhar Meerun, Carole Allimant, B. Rivière, A. Herrero +5 more
2022Hepatobiliary surgery and nutrition19 citations Open access
Semantic Scholar
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
E. Assenat, C. de la Fouchardiére, F. Portales, M. Ychou +6 more
2021ESMO Open19 citations Open access
Semantic Scholar
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma
A. Herrero, L. Boivineau, Gianluca Cassese, E. Assenat +7 more
2022Transplant International17 citations Open access
Semantic Scholar
Anticancer Drugs for Intra-Arterial Treatment of Colorectal Cancer Liver Metastases: In-Vitro Screening after Short Exposure Time
A. Fohlen, K. Bordji, E. Assenat, C. Gongora +7 more
2021Pharmaceuticals17 citations Open access
Semantic Scholar
Atezolizumab and bevacizumab for non‐resectable or metastatic combined hepatocellular‐cholangiocarcinoma: A multicentric retrospective study
E. Gigante, M. Bouattour, J. U. Bedoya, H. Regnault +8 more
2023United European Gastroenterology journal16 citations Open access
Semantic Scholar
LBA57 Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)
T. Conroy, P. Hammel, A. Turpin, C. Belletier +16 more
2021Annals of Oncology16 citations Open access
Semantic Scholar
Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial).
H. Pereira, Mohamed Bouattour, Marco Dioguardi Burgio, E. Assenat +4 more
2021European Journal of Cancer16 citations Open access
Semantic Scholar
Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study
T. Mazard, L. Cayrefourcq, F. Perriard, H. Sénellart +12 more
2021Cancers16 citations Open access
Semantic Scholar
Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!
B. Guiu, E. Assenat
2020Annals of Translational Medicine16 citations Open access
Semantic Scholar
Prolonged Survival after Recurrence in HCC Resected Patients Using Repeated Curative Therapies: Never Give Up!
Cyprien Toubert, B. Guiu, Bader Al Taweel, E. Assenat +5 more
2022Cancers15 citations Open access
Semantic Scholar
A prospective registry study of Stereotactic Magnetic Resonance guided Radiotherapy (MRgRT) for primary liver tumors.
K. Bordeau, M. Michalet, Valérie Dorion, A. Keskes +15 more
2023Radiotherapy and Oncology14 citations Open access
Semantic Scholar
Oncological Outcomes after Liver Venous Deprivation for Colorectal Liver Metastases: A Single Center Experience
Salah Khayat, Gianluca Cassese, F. Quénet, C. Cassinotto +4 more
2021Cancers14 citations Open access
Semantic Scholar
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
Marie Dupuy, S. Iltache, B. Rivière, A. Prieur +5 more
2022Cancers12 citations Open access
Semantic Scholar
A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score
C. Maulat, C. Canivet, C. Touraine, S. Gourgou +10 more
2020Cancers12 citations Open access
Semantic Scholar
Survival after Multimodal Treatment Including Surgery for Metastatic Esophageal Cancer: A Systematic Review
T. Bardol, L. Ferré, Safa Aouinti, Marie Dupuy +4 more
2022Cancers11 citations Open access
Semantic Scholar
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
C. Neuzillet, P. Artru, E. Assenat, J. Edeline +5 more
2023Targeted oncology10 citations Open access
Semantic Scholar
Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation
M. Hermida, Ancelin Preel, E. Assenat, L. Piron +7 more
2020Hepatology Communications10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Guiu×13
Invite
B. Guiu — researcher profile on SciRah
M. Ychou×11
Invite
M. Ychou — researcher profile on SciRah
J. Edeline×9
Invite
J. Edeline — researcher profile on SciRah
P. Merle×8
Invite
P. Merle — researcher profile on SciRah

×6

Invite

R. Finn — researcher profile on SciRah

Invite

T. Mazard — researcher profile on SciRah

Invite

Marie Dupuy — researcher profile on SciRah

Invite

F. Panaro — researcher profile on SciRah

Invite

M. Kudo — researcher profile on SciRah

Invite

G. Pageaux — researcher profile on SciRah

Invite

J. Blanc — researcher profile on SciRah

C. Cassinotto×5

Invite

C. Cassinotto — researcher profile on SciRah